Cargando…

Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma

OBJECTIVES: Fatty infiltration (FI) in the pancreas is positively correlated with high body mass index (BMI) or obesity, and the prevalence of diabetes mellitus (DM), which are well-known risk factors of pancreatic cancer. However, the association of FI in the pancreas with pancreatic cancer is uncl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hori, Mika, Takahashi, Mami, Hiraoka, Nobuyoshi, Yamaji, Taiki, Mutoh, Michihiro, Ishigamori, Rikako, Furuta, Koh, Okusaka, Takuji, Shimada, Kazuaki, Kosuge, Tomoo, Kanai, Yae, Nakagama, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972693/ https://www.ncbi.nlm.nih.gov/pubmed/24622469 http://dx.doi.org/10.1038/ctg.2014.5

Ejemplares similares

Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans
por: Takahashi, Mami, et al.
Publicado: (2018)

Arginase II Expressed in Cancer-Associated Fibroblasts Indicates Tissue Hypoxia and Predicts Poor Outcome in Patients with Pancreatic Cancer
por: Ino, Yoshinori, et al.
Publicado: (2013)

Experimental Animal Models of Pancreatic Carcinogenesis for Prevention Studies and Their Relevance to Human Disease
por: Takahashi, Mami, et al.
Publicado: (2011)

Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer
por: Gotoda, Takuji, et al.
Publicado: (1998)

Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma
por: Iwasaki, Toshimitsu, et al.
Publicado: (2019)

Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice
por: Ishigamori, Rikako, et al.
Publicado: (2017)

Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma
por: Doi, Noriteru, et al.
Publicado: (2020)

Reliable evaluation of tumor-infiltrating lymphocytes in pancreatic cancer tissue biopsies
por: Ino, Yoshinori, et al.
Publicado: (2019)

Lipoprotein Lipase as a Candidate Target for Cancer Prevention/Therapy
por: Takasu, Shinji, et al.
Publicado: (2012)

Involvement of NADPH oxidases in suppression of cyclooxygenase-2 promoter-dependent transcriptional activities by sesamol
por: Shimizu, Satomi, et al.
Publicado: (2015)

Diagnosis and Prognostication of Ductal Adenocarcinomas of the Pancreas Based on Genome-Wide DNA Methylation Profiling by Bacterial Artificial Chromosome Array-Based Methylated CpG Island Amplification
por: Gotoh, Masahiro, et al.
Publicado: (2011)

Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer
por: Hiraoka, N, et al.
Publicado: (2015)

Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling
por: Endo, Yutaka, et al.
Publicado: (2021)

Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
por: Ino, Y, et al.
Publicado: (2013)

Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma
por: Furukawa, Daisuke, et al.
Publicado: (2017)

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
por: Takai, Erina, et al.
Publicado: (2015)

Understanding Carcinogenesis for Fighting Oral Cancer
por: Tanaka, Takuji, et al.
Publicado: (2011)

Suppressive effects of the NADPH oxidase inhibitor apocynin on intestinal tumorigenesis in obese KK‐A (y) and Apc mutant Min mice
por: Komiya, Masami, et al.
Publicado: (2015)

Clinical characteristics of pancreatic and biliary tract cancers associated with Lynch syndrome
por: Takamizawa, Shigemasa, et al.
Publicado: (2021)

Risk factors for interstitial lung disease induced by gemcitabine plus albumin-bound paclitaxel therapy in pancreatic ductal adenocarcinoma patients
por: Ueda, Rikako, et al.
Publicado: (2022)

Antibody-based proteomics to identify an apoptosis signature for early recurrence of hepatocellular carcinoma
por: Morofuji, Noriaki, et al.
Publicado: (2016)

Clinical significance of tumor‐infiltrating immune cells focusing on BTLA and Cbl‐b in patients with gallbladder cancer
por: Oguro, Seiji, et al.
Publicado: (2015)

Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
por: Okusaka, Takuji, et al.
Publicado: (2023)

Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma
por: Mori, Taiki, et al.
Publicado: (2018)

Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation
por: Hiraoka, N, et al.
Publicado: (2010)

Biomarkers for Colorectal Cancer
por: Tanaka, Takuji, et al.
Publicado: (2010)

Effect of Heavy Alcohol Intake on Long‐term Results after Curative Resection of Hepatitis C Virus‐related Hepatocellular Carcinoma
por: Okada, Shuichi, et al.
Publicado: (1996)

Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines
por: Okusaka, Takuji, et al.
Publicado: (2020)

Liver atrophy after percutaneous transhepatic portal embolization occurs in two histological phases: Hepatocellular atrophy followed by apoptosis
por: Iwao, Yasuhito, et al.
Publicado: (2017)

Genome-Wide Association Study of Pancreatic Cancer in Japanese Population
por: Low, Siew-Kee, et al.
Publicado: (2010)

Endoscopic treatment of large impacted pancreatic ductal stone using digital pancreatoscopy and electrohydraulic lithotripsy
por: Shibuya, Hitoshi, et al.
Publicado: (2018)

Cancer Chemopreventive Ability of Conjugated Linolenic Acids
por: Tanaka, Takuji, et al.
Publicado: (2011)

Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms
por: Honda, Kazufumi, et al.
Publicado: (2015)

Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients
por: Hiraoka, Nobuyoshi, et al.
Publicado: (2020)

Pancreatic ductal hyperplasia/dysplasia with obstructive chronic pancreatitis: an association with reduced pancreatic weight in type 1 diabetes
por: Kobayashi, Tetsuro, et al.
Publicado: (2016)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
por: Suzuoki, M, et al.
Publicado: (2002)

Altered Plasma Apolipoprotein Modifications in Patients with Pancreatic Cancer: Protein Characterization and Multi-Institutional Validation
por: Honda, Kazufumi, et al.
Publicado: (2012)

Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma
por: Gu, Yuan, et al.
Publicado: (2019)

Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma
por: Katsuta, Eriko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d90ddjcvpdcnpi2ard4m014t2g